Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites

Expression of Concern for ‘Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites’ by Maorong Wang et al., RSC Adv., 2020, 10, 8044–8053, https://doi.org/10.1039/C9RA10593J.

Detalles Bibliográficos
Autores principales: Wang, Maorong, Yao, Ping, Gao, Minpeng, Jin, Jian, Yu, Yerong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679917/
https://www.ncbi.nlm.nih.gov/pubmed/36425214
http://dx.doi.org/10.1039/d2ra90118h
_version_ 1784834304296091648
author Wang, Maorong
Yao, Ping
Gao, Minpeng
Jin, Jian
Yu, Yerong
author_facet Wang, Maorong
Yao, Ping
Gao, Minpeng
Jin, Jian
Yu, Yerong
author_sort Wang, Maorong
collection PubMed
description Expression of Concern for ‘Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites’ by Maorong Wang et al., RSC Adv., 2020, 10, 8044–8053, https://doi.org/10.1039/C9RA10593J.
format Online
Article
Text
id pubmed-9679917
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-96799172022-11-23 Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites Wang, Maorong Yao, Ping Gao, Minpeng Jin, Jian Yu, Yerong RSC Adv Chemistry Expression of Concern for ‘Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites’ by Maorong Wang et al., RSC Adv., 2020, 10, 8044–8053, https://doi.org/10.1039/C9RA10593J. The Royal Society of Chemistry 2022-11-22 /pmc/articles/PMC9679917/ /pubmed/36425214 http://dx.doi.org/10.1039/d2ra90118h Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Wang, Maorong
Yao, Ping
Gao, Minpeng
Jin, Jian
Yu, Yerong
Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites
title Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites
title_full Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites
title_fullStr Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites
title_full_unstemmed Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites
title_short Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites
title_sort expression of concern: novel fatty chain-modified glp-1r g-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679917/
https://www.ncbi.nlm.nih.gov/pubmed/36425214
http://dx.doi.org/10.1039/d2ra90118h
work_keys_str_mv AT wangmaorong expressionofconcernnovelfattychainmodifiedglp1rgproteinbiasedagonistexertsprolongedantidiabeticeffectsthroughtargetingreceptorbindingsites
AT yaoping expressionofconcernnovelfattychainmodifiedglp1rgproteinbiasedagonistexertsprolongedantidiabeticeffectsthroughtargetingreceptorbindingsites
AT gaominpeng expressionofconcernnovelfattychainmodifiedglp1rgproteinbiasedagonistexertsprolongedantidiabeticeffectsthroughtargetingreceptorbindingsites
AT jinjian expressionofconcernnovelfattychainmodifiedglp1rgproteinbiasedagonistexertsprolongedantidiabeticeffectsthroughtargetingreceptorbindingsites
AT yuyerong expressionofconcernnovelfattychainmodifiedglp1rgproteinbiasedagonistexertsprolongedantidiabeticeffectsthroughtargetingreceptorbindingsites

Ejemplares similares